/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Milton Packer is the Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center at Dallas and Visiting Professor at Imperial College, London. He is an internationally recognized clinical investigator who has made many seminal contributions to the field of heart failure, both in understanding its mechanisms and defining its rational management. Spanning nearly 50 years, his work with ACE inhibitors, beta-blockers, angiotensin neprilysin and SGLT2 inhibitors established the cornerstones of the modern treatments for heart failure. He proposed the neurohormonal hypothesis of heart failure in 1992; he has led 20 large-scale international trials in heart failure; and he has received many international awards in recognition of his achievements. His popular and iconoclastic column on MedPage Today received the Jesse H. Neal Award, the equivalent of the Pulitzer Prize for business journalism. He has received both the Gold Medal and the Silver Medal from the ESC.
